R Squared’s Aehr Test Systems AEHR Stock Holding History

R Squared’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299K	Buy	+3,115	New	+$285K	0.16%	222
2025 Q1	–	Sell	-570	Closed	-$9.48K	–	313
2024 Q4	$9.48K	Buy	+570	New	+$7.6K	0.01%	1169

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

R Squared's AEHR Position: Q2 2026 in Review

R Squared opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 3,115 shares worth $299K. The stake represents 0.16% of the portfolio and ranks #222 among its holdings. This is a return to the name: R Squared previously reported a position in AEHR as recently as Q4 2024.

R Squared first reported a position in AEHR in Q4 2024 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

R Squared held 3,115 shares of Aehr Test Systems worth $299K as of Q2 2026.
Aehr Test Systems was a new R Squared position in Q2 2026.
Aehr Test Systems made up 0.16% of R Squared's portfolio in Q2 2026, its #222 holding.
R Squared first reported a position in Aehr Test Systems in Q4 2024 and has held it in 2 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.